Stockreport

UPDATE 1-Neurocrine gets U.S. approval for Parkinson's therapy, COVID-19 delays launch [Reuters]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF UPDATE 1-Neurocrine gets U.S. approval for Parkinson's therapy, COVID-19 delays launch (Adds details on pricing, comment from company, background) By Dania Nadeem April [Read more]